Bruker Expands Microbiology and Infection Diagnostics Portfolio
New updates include expanded capabilities for microbial identification and advancements in sepsis diagnostics and sequencing workflows.
Read MorePosted by CLP Edit Staff | Jun 16, 2026 | Mass Spectrometry, Microbiology, Molecular Diagnostics |
New updates include expanded capabilities for microbial identification and advancements in sepsis diagnostics and sequencing workflows.
Read MorePosted by CLP Edit Staff | Jun 16, 2026 | Flu & Respiratory Infections, Molecular Diagnostics |
The system simultaneously detects RSV, influenza A and B, and SARS-CoV-2 from a nasal swab in under 10 minutes.
Read MorePosted by CLP Edit Staff | Jun 12, 2026 | Anatomic Pathology, Cancer, Diagnostic Technologies |
The companion diagnostic evaluates mismatch repair deficiency, a predictive biomarker used to identify patients who may respond to PD-1-targeted therapies.
Read MorePosted by CLP Edit Staff | Jun 12, 2026 | Cardiovascular, Heart Disease |
A simplified test of HDL’s ability to remove cholesterol was associated with high-risk coronary plaques in a study of 61 patients.
Read MorePosted by CLP Edit Staff | Jun 10, 2026 | Diabetes & Metabolic Diseases |
Hepta’s blood test identified treatment-eligible MASH patients more accurately than current non-invasive methods in a 528-patient study, according to data presented at the EASL 2026 Congress.
Read More